Radiofrequency Microtenotomy for Treatment of Rotator Cuff Tendinopathy

University Hospital of North Norway34 enrolled

Overview

This study compare the outcome (pain, function) after Radiofrequency microtenotomy (group I) and acromioplasty (group II) for treatment of rotator cuff tendinosis in the shoulder. The outcome of both methods will be compared to the physical therapy treatment (groupIII)

Rotator cuff tendinosis cause pain and disability of the shoulder. Tendinosis, sometimes complicated by partial rupture, appears to be the major lesion in chronic rotator cuff tendinopathy. Important features is a poor intrinsic ability to heal. Several patients receive treatment for shoulder tendinosis each year. Conservative treatments options include rest, stretching, strengthening, ice and/or physical therapy are used with difference results. A traditional surgical treatments (acromioplasty) have been reported with variable results.. The aim of this study is to evaluate improvement of VAS and functionality using Constant score before and after treatment of rotator cuff tendinosis using radiofrequency-plasma based microtenotomy in comparison to traditional acromioplasty and physical therapy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Shoulder Impingement Syndrome

Interventions

Arthroscopic acromioplastyPROCEDURE

Surgical intervention With arthroscopic acromion resection

MicrotenotomyPROCEDURE

Arthroscopic radiofrequency microtenotomy of rotator cuff tendon

Eligibility

Sex: ALLMin age: 30 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Impingement pain in the shoulder at least 3 months * MRI of shoulder reveal tendinosis * Classification of Acromion morphology by RTG and or MRI * daily pain Exclusion Criteria: * inflammatory joint disease * Other comorbidity in the shoulder as instability, osteoarthritis or rotator cuff tear * serious illness

Locations (1)

University Hospital of North Norway

Tromsø, Norway

Outcomes

Primary Outcomes

Change from baseline in VAS for pain

The patients will have a clinical control 6,12 weeks and 6 months postoperatively. The VAS will be registered every 2 weeks via SMS during 6 months

Time frame: every 2 weeks. during 6 months

Change from baseline in VAS for pain,

Time frame: 6 weeks, 6 months, and 12 months

Secondary Outcomes

Change from baseline in functionality measured by constant score

Time frame: 6 weeks, 6 months and 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.